# Adaptive Closed-Loop Insulin Delivery System with Predictive Hypoglycemia Prevention

## Authors
Dr. Sarah Chen, Dr. Michael Park
Department of Biomedical Engineering, Stanford University

## Abstract

We present an adaptive closed-loop insulin delivery system that integrates continuous glucose monitoring (CGM) with a novel predictive algorithm to prevent hypoglycemic events before they occur. Unlike existing artificial pancreas systems that rely on reactive PID controllers or simple model predictive control (MPC), our system uses a patient-specific recurrent neural network (RNN) trained on 14 days of individual glucose data to predict blood glucose levels 60 minutes ahead with a mean absolute error of 8.2 mg/dL.

## Method

### 1. Dual-Horizon Prediction Architecture

The system employs two prediction models operating at different time horizons:

- **Short-horizon (15 min)**: A lightweight LSTM network processes the last 2 hours of CGM readings (sampled at 5-min intervals, 24 data points) to predict the next 15-minute glucose trajectory. This model runs every minute on the pump's embedded processor (ARM Cortex-M4, 168 MHz).

- **Long-horizon (60 min)**: A larger transformer-based model incorporates meal announcements, insulin-on-board calculations, and physical activity data (from an integrated accelerometer) to predict glucose 60 minutes ahead. This model runs every 5 minutes and is computationally heavier (~200ms inference).

### 2. Suspension-Before-Low (SBL) Algorithm

When the long-horizon model predicts glucose will drop below 70 mg/dL within 60 minutes with >80% confidence:
1. Insulin delivery is suspended immediately
2. A micro-dose of glucagon (150 μg) is delivered via a secondary reservoir
3. The short-horizon model monitors recovery trajectory
4. Insulin delivery resumes when predicted glucose exceeds 100 mg/dL with >90% confidence

### 3. Personalized Model Adaptation

The RNN weights are updated daily using federated learning principles — the model adapts to the patient's changing insulin sensitivity without sending raw glucose data to the cloud. Only gradient updates (differential privacy, ε=3.0) are transmitted to improve the global model.

## Results

Clinical trial with 45 Type 1 diabetes patients over 3 months:
- Time in range (70-180 mg/dL): 78.3% → 89.1% (p<0.001)
- Hypoglycemic events (<54 mg/dL): reduced by 82%
- Nocturnal hypoglycemia: reduced by 94%
- No severe hypoglycemic events requiring external assistance
- Mean HbA1c improvement: 0.6% (from 7.2% to 6.6%)

## Claims

1. A closed-loop insulin delivery system comprising:
   a continuous glucose monitor configured to sample blood glucose at intervals of 5 minutes or less;
   a first prediction module implementing a recurrent neural network trained on patient-specific glucose data, configured to predict glucose levels 15 minutes ahead;
   a second prediction module implementing a transformer architecture, configured to predict glucose levels 60 minutes ahead using glucose data, insulin-on-board calculations, and physical activity data;
   a dual-reservoir pump containing both insulin and glucagon;
   a controller configured to suspend insulin delivery and administer a micro-dose of glucagon when the second prediction module predicts glucose below 70 mg/dL with greater than 80% confidence.

2. The system of claim 1, wherein the first prediction module processes the most recent 24 sequential CGM readings and executes on an embedded processor at one-minute intervals.

3. The system of claim 1, wherein the recurrent neural network weights are updated daily using federated learning with differential privacy guarantees.
